Sera Prognostics to Present at the Baird 2017 Global Healthcare Conference
05 sept. 2017 10h49 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...
Sera Prognostics Receives Accreditation from College of American Pathologists
29 juin 2017 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 29, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that the Accreditation Committee of the College of American Pathologists (CAP)...
Sera Prognostics Announces Analytical Validation Study Published in Clinical Mass Spectrometry
26 juin 2017 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 26, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that its recent analytical study, Analytical Validation of Protein Biomarkers...
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
17 mai 2017 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, May 17, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that Nadia F. Altomare has joined the company as chief commercial officer....
Sera Prognostics is Named a 2017 Silver Edison Award Winner
21 avr. 2017 07h00 HE
|
Sera Prognostics, Inc.
NEW YORK, April 21, 2017 (GLOBE NEWSWIRE) -- The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced...
Research on Fetal Sex Differences in Predicting Spontaneous Preterm Birth Using Sera’s Proteomic Technology to be Presented at The 64th Annual Society for Reproductive Investigation Meeting
13 mars 2017 14h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 13, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that research using Sera’s innovative proteomic technology platform that...
Sera Prognostics’ PreTRM® Named Edison Awards Finalist
09 févr. 2017 12h50 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s heath company, today announced that PreTRM®, the first and only clinically-validated blood test that provides an early...
Research on Underlying Mechanisms of Pregnancy Complications and Medical Interventions Using Sera’s Proteomic Technology to be Presented at the Society for Maternal-Fetal Medicine’s 37th Annual Pregnancy Meeting
23 janv. 2017 15h08 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 23, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced the presentation of ongoing research evaluating the underlying mechanisms of...
Sera Prognostics Enters into Agreement with LabCorp to be the Exclusive U.S. Distributor of PreTRM® Test
10 janv. 2017 07h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a woman’s healthcare company, announced today that it has entered into a strategic collaboration with Laboratory Corporation...
Two Peer-Reviewed Publications Highlight Clinical Utility of PreTRM® Test
19 déc. 2016 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced the recent publication of two reports showing significant clinical utility of...